Microbial biodiscovery: Back to the future

Current Topics in Medicinal Chemistry

Volumn 12, Issue 14, 2012, Pages 1471-1478

  Capon, Robert J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bacteria; Fungi; Microbial biodiscovery; Natural products

Indexed keywords

CALICHEAMICIN DERIVATIVE; CALICHEAMICIN GAMMA1; DAPTOMYCIN; INDOLACTAM V; PLATENSIMYCIN; SALINOSPORAMIDE A;

ARTICLE; DRUG IDENTIFICATION; DRUG RESEARCH; GENE ACTIVATION; INVESTMENT; MEDICAL RESEARCH; MICROBIAL BIODISCOVERY; MICROBIAL METABOLISM; MICROBIOLOGICAL EXAMINATION; MULTIPLE MYELOMA; NONHUMAN; SILENT GENE;

ANIMALS; BACTERIA; BIOLOGICAL AGENTS; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; FUNGI; HUMANS; MICROBIOLOGY;

EID: 84866937316     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612802652394     Document Type: Article

References (35)

1. Fischbach, M. A.; Walsh, C. T. Antibiotics for emerging pathogens. Science, 2009, 325, 1089-1093.
2. Silver, L. L. Challenges of antibiotic discovery. Clin. Microbiol. Rev., 2011, 24, 71-109.
3. Lee, M.D.; Manning, J.K. Williams, D.R.; Kuck, N.A.; Testa, R.T.; Borders, D.B. Calicheamicins. A novel class of antitumour antibiotics. J. Antibiot., 1989, 42, 1070-1087.
4. Zazopoulos, E.; Huang, K.X.; Staffa, A.; Liu, W.; Bachmann, B.O.; Nonaka, K.; Ahlert, J.; Thorson, J.S.; Shen, B.; Farnet, C.M. A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nature Biotech., 2003, 21, 187-190.
5. Steenbergen, J.N.; Alder, J.; Thorne, G.M.; Tally, F.P. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrobial Chemo., 2005, 55, 283-288.
6. Wang, J.; Soisson, S.M.; Young, K.; Wesley Shoop, W.; Kodali, S.; Galgoci, A.; Painter, R.; Parthasarathy, G.; Tang, Y.S.; Cummings, R.; Ha, S.; Dorso, K.; Motyl, M.; Jayasuriya, H.; Ondeyka, J.; Herath, K.; Zhang, C.; Hernandez, L.; Allocco, J.; Basilio, A.; Tormo, J.R.; Genilloud, O.; Vicente, F.; Pelaez, F.; Colwell, L.; Lee, S.H.; Michael, B.; Felcetto, T.; Gill, C.; Silver, L.L.; Hermes, J.D.; Bartizal, K.; Barrett, J.; Schmatz, D.; Becker, J.W.; Cully, D.; Singh, S.B. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature, 2006, 441, 358-361.
7. Feling, R.H.; Buchanan, G.O. Mincer, T.J.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew. Chem. Int. Ed., 2003, 42, 355-357.
8. Chauhan, D.; Catley, L.; Li, G.; Podar, K.; Hideshima, T.; Velankar, M.; Mitsiades, C.; Mitsiades, N.; Yasui, H.; Letai, A.; Ovaa, H.; Berkers, C.; Nicholson, B.; Chao, T.-H.; Neuteboom, S.T.C.; Richardson, P.; Palladino, M. A.; Anderson, K.C. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib. Cancer Cell, 2005, 8, 407-419.
9. Chen, S.; Borowiak, M.; Fox, J. L.; Maehr, R.; Osafune, K.; Davidow, L.; Lam, K.; Peng, L.F.; Schreiber, S.L.; Rubin, L.L.; Melton, D. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nature Chem. Biol., 2009, 5, 258-265.
10. Zhu, S.T.; Wurdak, H.; Wang, J.; Lyssiotis, C.A.; Peters, E.C.; Cho, C.Y.; Wu. X.; Schultz, P. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell, 2009, 4, 416-426.
11. Zhan, Y.P.; Du, X.P.; Chen, H.; Liu, J.; Zhao, B.; Huang, D.; Li, G.; Xu, Q.; Zhang, M.; Weimer, B.C.; Chen, D.; Cheng, Z.; Zhang, L.; Li, Q.; Li, S.; Zheng, Z.; Song, S.; Huang, Y.; Ye, Z.; Su, W.; Lin, S.-C.; Shen, Y.; Wu, Q., Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nature Chem. Biol., 2008, 4, 548-556.
12. Liu, X.; Ashforth, E.; Ren, B.; Song, F.; Dai, H.; Liu, M.; Wang, J.; Xie, Q.; Zhang, L. Bioprospecting microbial natural product libraries from the marine environment for drug discovery. J. Antibiot., 2010, 63, 415-422.
13. Waters, A.L.; Hill, R.T.; Place, A.R.; Hamann, M.T. The expanding role of marine microbes in pharmaceutical development. Curr. Opin. Biotech., 2010, 21, 780-786.
14. McAlpine, J.B.; Bachmann, B.O.; Piraee, M. Tremblay, S.; Alarco, A.-M.; Zazopoulos, E.; Farnet, C.M. Microbial genomics as a guide to drug discovery and structure elucidation: ECO-02301, a novel antifungal agent, as an example. J. Nat. Prod., 2005, 68, 493-496.
15. Udwary, D.W.; Zeigler, L.; Asolkar, R.N.; Singan, V.; Lapidus, A.; Fenical, W.; Jensen, P.R.; Moore, B.S. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. PNAS, 2007, 104, 10376-10381.
16. Breitling, R.; Vitkup, D.; Barrett, M.P. New surveyor tools for charting microbial metabolic maps. Nature Reviews-Microbiology, 2008, 6, 156-161.
17. Omura, S.; Ikeda, H.; Ishikawa, J.; Hanamoto, A.; Takahashi, C.; Shinose, M.; Takahashi, Y.; Horikawa, H.; Nakazawa, H.; Osonoe, T.; Kikuchi, H.; Shibai, T.; Sakaki, Y.; Hattori, M., Genome sequence of an industrial microorganism Streptomyces avermitilis: Deducing the ability of producing secondary metabolites. Proc. Natl Acad. Sci. 2001, 98, 12215-12220.
18. Bentley, S. D.; Chater, K. F.; Cerdeno-Tarraga, A. M.; Challis, G. L.; Thomson, N. R.; James, K. D.; Harris, D. E.; Quail, M. A.; Kieser, H.; Harper, D.; Bateman, A.; Brown, S.; Chandra, G.; Chen, C. W.; Collins, M.; Cronin, A.; Fraser, A.; Goble, A.; Hidalgo, J.; Hornsby, T.; Howarth, S.; Huang, C. H.; Kieser, T.; Larke, L.; Murphy, L.; Oliver, K.; O'Neil, S.; Rabbinowitsch, E.; Rajandream, M. A.; Rutherford, K.; Rutter, S.; Seeger, K.; Saunders, D.; Sharp, S.; Squares, R.; Squares, S.; Taylor, K.; Warren, T.; Wietzorrek, A.; Woodward, J.; Barrell, B. G.; Parkhill, J.; Hopwood, D. A., Complete genome sequence of the model actinomycete Streptomycescoelicolor A3(2). Nature, 2002, 417, 141-7.
19. Udwary, D. W.; Zeigler, L.; Asolkar, R. N.; Singan, V.; Lapidus, A.; Fenical, W.; Jensen, P. R.; Moore, B. S., Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Proc. Natl Acad. Sci. USA, 2007, 104, 10376-10381.
20. Hopwood, D. A., Therapeutic treasures from the deep. Nature Chemical Biology, 2007, 3, 457-458.
21. Cueto, M.; Jensen, P. R.; Kauffman, C.; Fenical, W.; Lobkovski, E.; Clardy, J., Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge. J. Nat. Prod., 2001, 64, 1444-1446.
22. Oh, D. C.; Jensen, P. R.; Kauffman, C. A.; Fenical, W., Libertellenones A-D: Induction of cytotoxic diterpenoid biosynthesis by marine microbial competition. Bioorg. & Med. Chem., 2005, 13, 5267-5273.
23. Oh, D. C.; Kauffman, C. A.; Jensen, P. R.; Fenical, W., Induced production of emericellamides A and B from the marine-derived fungus Emericella sp. in competing co-culture. J. Nat. Prod., 2007, 70, 515-520.
24. Ratnayake, R.; Lacey, E.; Tennant, S.; Gill, J. H.; Capon, R. J., Kibdelones: novel anticancer polyketides from a rare Australian actinomycete. Chem. Eur. J., 2007, 13, 1610-1619.
25. Ratnayake, R.; Lacey, E.; Tennant, S.; Gill, J. H.; Capon, R. J., Isokibdelones: novel heterocyclic polyketides from a Kibdelosporamgium sp. Org. Lett., 2006, 8, 5267-5270.
26. Kim, W.-G.; Song, N.-K.; Yoo, I.-D., Quinolactacins A1 and A2. New acetylcholinesterase inhibitors from Penicillium citrinum. J. Antibiot., 2001, 54, 831-835.
27. Takahashi, S.; Kakinuma, N.; Iwai, H.; Yanagisawa, T.; Nagai, K.; Suzuki, K.; Tokunaga, T.; Nakagawa, A., Quinolactacins A, B and C: Novel quinolone compounds from Penicillium sp EPF-6. II. Physico-chemical properties and structure elucidation. J. Antibiot., 2000, 53, 1252-1256.
28. Kakinuma, N.; Iwai, H.; Takahashi, S.; Hamano, K.; Yanagisawa, T.; Nagai, K.; Tanaka, K.; Suzuki, K.; Kirikae, F.; Kirikae T.; Nakagawa, A., Quinolactacins A, B and C: Novel quinolone compounds from Penicillium sp EPF-6. I. Taxonomy, production, isolation and biological properties. J. Antibiot., 2000, 53, 1247-1251.
29. Clark, B.; Capon, R. J.; Lacey, E.; Tennant, S.; Gill, J., Quinolactacins revisited. From lactams to imide and beyond. Org. Biomol, Chem., 2006, 4, 1512-1519.
30. Clark, B.; Capon, R. J.; Lacey, E.; Tennant, S.; Gill, J., Citrinin revisited. From monomers to dimers and beyond. Org. Biomol, Chem., 2006, 4, 1520-1528.
31. Osada, H.; Koshino, H.; Isono, K.; Takahashi H.; Kawanishi, G., Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor. J. Antibiot., 1991, 44, 259-261.
32. Takahashi, H.; Osada, H.; Koshino, H.; Kudo, T.; Amano, S.; Shimizu, S.; Yoshihama, M.; Isono, K., Reveromycins, new inhibitors of eukaryotic cell growth. I. Producing organism, fermentation, isolation and physicochemical properties. J. Antibiot., 1992, 45, 1409-1413.
33. Takahashi, H.; Osada, H.; Koshino, H.; Sasaki, M.; Onose, R.; Nakakoshi, M.; Yoshihama, M.; Isono, K., Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities. J. Antibiot., 1992, 45, 1414-1419.
34. Koshino, H.; Takahashi, H.; Osada, H.; Isono, K., Reveromycins, new inhibitors of eukaryotic cell growth. III. Structures of reveromycins A, B, C and D. J. Antibiot., 1992, 45, 1420-1427.
35. Fremlin, L.; Farrugia, M.; Piggott, A. M.; Khalil, Z.; Lacey, E.; Capon, R. J., Reveromycins revealed: new polyketide spiroketals from Australian marine-derived and terrestrial Streptomyces spp. A case of natural products vs. artifacts. Org. Biomol. Chem., 2011, 9, 1201-1211.